Psoriasis induced by infliximab in a Saudi patient with ankylosing spondylitis
Saudi Medical Journal. 2010; 31 (9): 1054-1056
em Inglês
| IMEMR
| ID: emr-117678
ABSTRACT
Although the therapeutic uses of tumor necrosis factor alpha antagonists have added a highly effective treatment of ankylosing spondylitis and associated spondyloarthropathies, they are associated with many untoward effects. We describe a Saudi patient with ankylosing spondylitis who developed severe psoriatic lesions in treatment with infliximab. He had no personal, or family history of psoriasis, and no other triggering factors known to induce psoriasis
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Espondilite Anquilosante
/
Anti-Inflamatórios
/
Anticorpos Monoclonais
Tipo de estudo:
Relato de Casos
Limite:
Adulto
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Saudi Med. J.
Ano de publicação:
2010
Similares
MEDLINE
...
LILACS
LIS